title: Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infection.
authors.forename: Marlous L
authors.initials: ML
authors.lastname: Grijsen
authors.forename: Rebecca
authors.initials: R
authors.lastname: Holman
authors.forename: Ferdinand W N M
authors.initials: FW
authors.lastname: Wit
authors.forename: Luuk
authors.initials: L
authors.lastname: Gras
authors.forename: Selwyn H
authors.initials: SH
authors.lastname: Lowe
authors.forename: Kees
authors.initials: K
authors.lastname: Brinkman
authors.forename: Frank
authors.initials: F
authors.lastname: de Wolf
authors.forename: Jan M
authors.initials: JM
authors.lastname: Prins
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology*; D000328:Adult; D018791:CD4 Lymphocyte Count; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005260:Female; D015497:HIV-1 / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D008297:Male; D011446:Prospective Studies; D012367:RNA, Viral / Q000187:drug effects; D016896:Treatment Outcome; D019562:Viral Load / Q000187:drug effects* / Q000276:immunology
chemical_list: D012367:RNA, Viral